Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 14(1)2021 Jan 28.
Article in English | MEDLINE | ID: mdl-33509864

ABSTRACT

We report the case of a 69-year-old man, who presented in the UK with a short history of deteriorating vision and clinical features of bilateral atypical retinochoroiditis, after travelling to South America. Vitreous samples demonstrated Toxoplasma gondii DNA by PCR. Serology tests demonstrated recent acquired Toxoplasma gondii infection with IgM antibodies. He responded well to treatment with trimethoprim-sulfamethoxazole, azithromycin and oral steroids.This case is a reminder of the global importance of Toxoplasma related eye disease, and its uncommon bilateral severe presentation in a returning traveller, where the risk factors were age and the route of infection likely to be a virulent parasite oocyst from vegetables or water rather than undercooked meat or direct contact with cats.


Subject(s)
Toxoplasmosis, Ocular/diagnosis , Travel-Related Illness , Age Factors , Aged , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Fundus Oculi , Glucocorticoids/therapeutic use , Humans , Male , South America , Tomography, Optical Coherence , Toxoplasmosis, Ocular/drug therapy , Toxoplasmosis, Ocular/pathology , Toxoplasmosis, Ocular/transmission , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , United Kingdom
4.
Eur J Ophthalmol ; 19(3): 490-3, 2009.
Article in English | MEDLINE | ID: mdl-19396803

ABSTRACT

PURPOSE: Despite the increasing use of antivascular endothelial growth factors (anti-VEGF), photodynamic therapy (PDT) with Verteporfin is still considered the gold standard treatment of subfoveal and juxtafoveal classic choroidal neovascularization (CNV). METHODS: Case report. RESULTS: The authors report a case of a 72-year-old man who developed choroidal nonperfusion and significant subretinal fluid formation with associated severe visual loss following PDT of predominantly classic juxtafoveal CNV. CONCLUSIONS: Although reported separately, these two complications have not been previously reported to occur in association after PDT treatment of classic CNV and may represent exaggeration of normal events occurring after PDT.


Subject(s)
Choroid/blood supply , Choroidal Neovascularization/drug therapy , Ischemia/etiology , Photochemotherapy/adverse effects , Retinal Diseases/etiology , Aged , Atrophy , Exudates and Transudates , Fluorescein Angiography , Humans , Indocyanine Green , Ischemia/diagnosis , Male , Ophthalmoscopy , Photosensitizing Agents/adverse effects , Porphyrins/adverse effects , Retinal Diseases/diagnosis , Retinal Pigment Epithelium/pathology , Tomography, Optical Coherence , Verteporfin , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...